| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/14/2001 | US6274165 Patch for controlled delivery of oestradiol or its pharmaceutically acceptable derivatives |
| 08/14/2001 | US6274162 For aqueous film coating of pharmaceutical, food, confectionery, and agricultural seeds; coatings having gloss, smoothness |
| 08/14/2001 | US6274161 Compositions containing creatine in suspension |
| 08/14/2001 | US6274159 For prolonged release of biologically active substance |
| 08/14/2001 | US6274155 As absorbent with skin healing properties when incorporated into diapers, feminine hygiene products, wound dressings, including both human and veterinary uses, as soft tissue augmentation medium when used in subdermal implants; cosmetics |
| 08/14/2001 | US6274150 Nanoemulsion based on phosphoric acid fatty acid esters and its uses in the cosmetics, dermatological, pharmaceutical, and/or ophthalmological fields |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274133 Method for treating extended-wear contact lenses in the eyes |
| 08/14/2001 | US6274132 Applying to vagina and adnexa topical preparation selected from liquid solutions, suspensions, semi-solids, salves, creams, gels, and suppositories, preparation consisting of glycerine, hydroxyethyl cellulose, glucono delta lactone |
| 08/14/2001 | US6274124 Adding 1,2-pentanediol to cosmetic or dermatological active agent to improve water resistance |
| 08/14/2001 | US6274121 Superparamagnetic particles, process for their manufacture and use |
| 08/14/2001 | US6274116 Compositions for boron delivery to mammalian tissue |
| 08/14/2001 | US6274115 Providing micellular particles comprising phospholipid molecules which are stable to leakage in vitro and in vivo; modifying micellular partilces; introducing into blood stream; incorporatingagent for diagnosis or therapy into secnd group |
| 08/14/2001 | US6273092 Methods for treating various eye disorders |
| 08/14/2001 | CA2209868C Pharmaceutical compositions comprising cefuroxime axetil |
| 08/14/2001 | CA2150871C Cosmetic sunscreens made of a synergetic mix of filters and their uses |
| 08/14/2001 | CA2088778C Transdermal contraceptive formulations, methods and devices |
| 08/14/2001 | CA2083754C Stable vitamin and/or carotenoid products in powder form, and the preparation thereof |
| 08/14/2001 | CA2080907C Enzymatic synthesis of soluble phosphatides from phospholipids |
| 08/14/2001 | CA2038245C Pharmaceutically useful micropellets |
| 08/14/2001 | CA2035179C Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| 08/09/2001 | WO2001057234A2 Biopolymer thickener |
| 08/09/2001 | WO2001057144A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057064A2 Cationic amphiphiles for use in nucleic acid transfection |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057015A1 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
| 08/09/2001 | WO2001056611A1 Oral delivery of allergens in milk |
| 08/09/2001 | WO2001056597A1 Pharmaceutical carrier composition for papayne based products |
| 08/09/2001 | WO2001056594A1 Nasal calcitonin formulations |
| 08/09/2001 | WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation |
| 08/09/2001 | WO2001056581A1 Powdered preparation for inhalation and powder inhalant containing the same packed |
| 08/09/2001 | WO2001056576A1 Transdermal therapeutic system for the administration of zaleplon |
| 08/09/2001 | WO2001056575A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| 08/09/2001 | WO2001056563A1 Adamantyl derivatives as anti-cancer agents |
| 08/09/2001 | WO2001056562A1 Stable emulsion compositions |
| 08/09/2001 | WO2001056559A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent |
| 08/09/2001 | WO2001056550A1 Gellan gum dipped products |
| 08/09/2001 | WO2001056549A1 Continuous method for preparing pharmaceutical granules |
| 08/09/2001 | WO2001056548A2 Liposomes composition produced by a dehydration-rehydration process |
| 08/09/2001 | WO2001056547A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 08/09/2001 | WO2001056546A2 Magnetoliposome composition for targeted treatment of biological tissue |
| 08/09/2001 | WO2001056545A2 Sustained-release microencapsulated delivery system |
| 08/09/2001 | WO2001056544A2 Shell-and-core dosage form approaching zero-order drug release |
| 08/09/2001 | WO2001056543A1 Osmotically-driven fluid dispenser and coating composition |
| 08/09/2001 | WO2001056540A2 Device for applying active principles for pharmaceutical or cosmetic purposes |
| 08/09/2001 | WO2001056534A1 Clear water-in-oil emulsions |
| 08/09/2001 | WO2001056406A1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 08/09/2001 | WO2001056387A1 Immunotherapeutic treatment methodology for patients afflicted with superficial bladder cancer who previously failed at least one immunostimulatory therapeutic treatment regimen |
| 08/09/2001 | WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 08/09/2001 | WO2001019349A3 Extended release formulation of etodolac |
| 08/09/2001 | WO2001019342A3 Pharmaceutical formulation of fluticasone propionate |
| 08/09/2001 | WO2001019337A3 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 08/09/2001 | WO2001006988A3 Super-active porcine growth hormone releasing hormone analog |
| 08/09/2001 | WO2001000241A3 Novel vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000078272A3 Guerbet alcohols |
| 08/09/2001 | WO2000076452A3 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 08/09/2001 | WO2000074646A3 Novel liposomal vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000067728A3 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| 08/09/2001 | WO2000066173A3 Targeting of infectious agents bearing host cell proteins |
| 08/09/2001 | WO2000066100A3 2r,4s-hydroxyitraconazole isomers |
| 08/09/2001 | WO2000062813A3 Cationic peg-lipids and methods of use |
| 08/09/2001 | WO2000055072A3 Aerosol metering valve |
| 08/09/2001 | WO2000045795A3 Topical sprays comprising a film forming composition |
| 08/09/2001 | US20010012859 Incorporation of a C3-7 fatty acid, e.g., sorbic acid, improves the penetration of the beta-blocker, e.g., carteolol hydrochloride, into the eye and retention in the eye tissues; glaucoma; vision defects |
| 08/09/2001 | US20010012856 Compositions and methods for the treatment of anorectal disorders |
| 08/09/2001 | US20010012847 Methods and devices for providing prolonged drug therapy |
| 08/09/2001 | US20010012844 Quinazoline, nitrothiazole and indolinone based hydrophobic formulations for oral administration for treating cell proliferation disorder in a mammal |
| 08/09/2001 | US20010012837 Anti-ulcer composition |
| 08/09/2001 | US20010012834 Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| 08/09/2001 | US20010012522 Multilayer; shell, core |
| 08/09/2001 | US20010012521 Concurrent melting |
| 08/09/2001 | US20010012519 Method for coating pharmaceutical dosage forms |
| 08/09/2001 | US20010012518 Oral dosage |
| 08/09/2001 | US20010012511 Sterile barrier |
| 08/09/2001 | DE10005280A1 Partikuläre Zusammensetzung, Verfahren zu ihrer Herstellung und deren Verwendung Particulate composition, process for their preparation and their use |
| 08/09/2001 | DE10004790A1 Plaster-form transdermal therapeutic system containing zaleplon, especially for use as hypnotic agent, providing safe and controlled drug delivery |
| 08/09/2001 | DE10004547A1 Selective delivery of drugs to the central nervous system, e.g. for treatment of stress or depression, by administration to the olfactory region in doses inducing central nervous system action |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/09/2001 | CA2683185A1 Osmotically-driven fluid dispenser and coating composition |
| 08/09/2001 | CA2399294A1 Clear water-in-oil emulsions comprising reduced amounts of surfactant and glycol |
| 08/09/2001 | CA2399124A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| 08/09/2001 | CA2399123A1 Medicament for treating aseptic inflammations containing anemonin as effective component |
| 08/09/2001 | CA2399098A1 Pharmaceutical carrier composition for papayne based products |
| 08/09/2001 | CA2399034A1 Continuous method for preparing pharmaceutical granules |
| 08/09/2001 | CA2398996A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | CA2398889A1 Antisense modulation of survivin expression |
| 08/09/2001 | CA2397799A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
| 08/09/2001 | CA2396782A1 Shell-and-core dosage form approaching zero-order drug release |
| 08/08/2001 | EP1121941A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 08/08/2001 | EP1121935A1 Pharmaceutical composition containing a small or medium size peptide |
| 08/08/2001 | EP1121931A1 Controlled release oral preparations of esculetin and its derivatives |
| 08/08/2001 | EP1121930A1 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases |
| 08/08/2001 | EP1121929A1 Drug preparation "histochrome" for treating ocular conditions |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121375A1 High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one |
| 08/08/2001 | EP1121159A1 Vapour dispensing device |
| 08/08/2001 | EP1121145A1 Insulin preparations for pulmonary delivery containing menthol |
| 08/08/2001 | EP1121144A1 Stable concentrated insulin preparations for pulmonary delivery |